Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.
暂无分享,去创建一个
[1] G. Fleuren,et al. T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody. , 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.
[2] John W. Park,et al. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. , 1997, Biochemistry.
[3] V. Torchilin,et al. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.
[4] P. Volberding,et al. Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma , 1996, Journal of clinical pharmacology.
[5] N. Petrelli,et al. Metastatic colorectal cancer: advances in biochemical modulation and new drug development. , 1995, Seminars in oncology.
[6] P. Kuppen,et al. Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. , 1993, Invasion & metastasis.
[7] T M Allen,et al. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. , 1998, Cancer research.
[8] D. Machover. A comprehensive review of 5‐fluorouracil and leucovorin in patients with metastatic colorectal carcinoma , 1997, Cancer.
[9] N. Kemeny. Regional chemotherapy of colorectal cancer. , 1995, European journal of cancer.
[10] J. Kamps,et al. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells. , 1999, Biochimica et biophysica acta.
[11] G. Fleuren,et al. T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. II. Syngeneic colon carcinoma CC531 is efficiently killed by retargeted cytotoxic T lymphocytes in vitro despite limited lysis in 51Cr release assays. , 1993, Journal of immunology.
[12] E. Moase,et al. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. , 1995, Biochimica et biophysica acta.
[13] C. Benz,et al. Anti-HER2 immunoliposomes for targeted therapy of human tumors. , 1997, Cancer letters.
[14] M. van Galen,et al. In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives. , 1993, Biochimica et biophysica acta.
[15] Koning,et al. Immunoliposomes for the targeted delivery of antitumor drugs. , 1999, Advanced drug delivery reviews.
[16] J. Jeekel,et al. Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site , 1984, International journal of cancer.
[17] C. V. D. van de Velde,et al. Treatment of colorectal cancer metastases confined to the liver. , 1995, European journal of cancer.
[18] G. Scherphof,et al. UPTAKE AND PROCESSING OF IMMUNOGLOBULIN-COATED LIPOSOMES BY SUBPOPULATIONS OF RAT-LIVER MACROPHAGES , 1988 .
[19] John W. Park,et al. Development of anti-p185HER2 immunoliposomes for cancer therapy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Böttcher,et al. A rapid and sensitive sub-micro phosphorus determination , 1961 .
[21] G. Peters,et al. Comparison of 5-fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer. , 1998, European journal of cancer.
[22] H. Allgayer,et al. An immunohistochemical assessment of cathepsin D in gastric carcinoma , 1997, Cancer.
[23] J. Kamps,et al. Uptake of Long-Circulating Immunoliposomes, Directed Against Colon Adenocarcinoma Cells, by Liver Metastases of Colon Cancer , 2000, Journal of drug targeting.
[24] G. Koning,et al. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells , 1999, British Journal of Cancer.
[25] P. Danenberg. Thymidylate synthetase - a target enzyme in cancer chemotherapy. , 1977, Biochimica et biophysica acta.
[26] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[27] C. Myers. The pharmacology of the fluoropyrimidines. , 1981, Pharmacological reviews.
[28] S. Kinsky,et al. Synthesis and characterization of methotrexate-dimyristoylphosphatidylethanolamine derivatives and the glycerophosphorylethanolamine analogs. , 1985, Biochimica et biophysica acta.
[29] G. Scherphof,et al. An improved method for the covalent coupling of proteins to liposomes , 1985 .
[30] S. Zalipsky. Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. , 1993, Bioconjugate chemistry.
[31] T M Allen,et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.
[32] G. Peterson,et al. A simplification of the protein assay method of Lowry et al. which is more generally applicable. , 1977, Analytical biochemistry.
[33] A. Allison,et al. Liposomes in biological systems , 1980 .
[34] S. Kinsky,et al. Circumvention of the methotrexate transport system by methotrexate-phosphatidylethanolamine derivatives: effect of fatty acid chain length. , 1987, Biochimica et biophysica acta.
[35] W. M. Williams,et al. Dose-Dependent Elimination of 5-Fluoro-2′-deoxyuridine in the Monkey 1 , 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[36] Y. Yarden,et al. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. , 1996, British Journal of Cancer.
[37] S. Kennel,et al. Characterization of organ-specific immunoliposomes for delivery of 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine in a mouse lung-metastasis model , 2004, Cancer Chemotherapy and Pharmacology.
[38] R. New,et al. Liposomes : a practical approach , 1990 .
[39] P. Jap,et al. Design of immunoliposomes directed against human ovarian carcinoma. , 1995, Biochimica et biophysica acta.